click below
click below
Normal Size Small Size show me how
Neuro/Psych I
NEUROLOGICAL AND PSYCHIATRIC DISEASE 1
| Generic Name | Brand Name | Pharmacological Category | Common Indications | Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| atomoxetine (PO) | Strattera | Serotonin-norepinephrine reuptake inhbitor (SNRI) | ADHD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| desvenlafaxine (PO) | Pristiq | Serotonin-norepinephrine reuptake inhbitor (SNRI) | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| duloxetine (PO) | Cymbalta | Serotonin-norepinephrine reuptake inhbitor (SNRI) | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| milnacipran (PO) | Savella | Serotonin-norepinephrine reuptake inhbitor (SNRI) | Fibromyalgia | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| citalopram (PO) | Celexa | Selective serontonin reuptake inhibitor (SSRI) | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| fluoxetine (PO) | Prozac | Selective serontonin reuptake inhibitor (SSRI) | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| escitalopram (PO) | Lexapro | Selective serontonin reuptake inhibitor (SSRI) | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| paroxetine (PO) | Paxil | Selective serontonin reuptake inhibitor (SSRI) | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| sertraline (PO) | Zoloft | Selective serontonin reuptake inhibitor (SSRI) | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| trazodone (PO) | Desyrel | Seratonin reuptake inhibitor | Insomnia, MDD | sedation, headache, dizziness, dry mouth, nausea | antidepressants increase the risk of suicidal thinking and behavior in children, adolescents and young adults | |
| vilazodone (PO) | Viibryd | Selective serotonin reuptake inhibitor (SSRI)/5-HT1a partial agonist | MDD | headache, diarrhea, nausea, dizziness, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | |
| amitriptyline (PO) | Elavil | Tricyclic antidepressant (TCA) | MDD, diabetic neuropathy, migraine prophylaxis | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| imipramine (PO) | Tofranil | Tricyclic antidepressant (TCA) | MDD | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| nortriptyline (PO) | Pamelor | Tricyclic antidepressant (TCA) | MDD | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| doxepin (PO) | Silenor | Tricyclic antidepressant (TCA) | Insomnia | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| venlafaxine (PO) | Effexor, Effexor XR | Serotonin-norepinephrine reuptake inhbitor (SNRI) | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| mirtazapine (PO) | Remeron | Alpha2 Antagonist | MDD | drowsiness, weight gain, xerostomia, increased appetite, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | |
| bupropion (PO) | Wellbutrin SR, Wellbutrin XL | Norepinephrine-dopamine reuptake inhibitor | MDD | tachycardia, headache, agitation, dizziness, insomnia, weight loss | increased risk of suicidal thinking and behavior in children, adolescents, and young adults; serious neuropsychiatric reactions have occurred | use may increase risk of seizures (CI in patients with seizure disorders and/or eating disorders) |